Skeletal muscle energetics in patients with moderate to advanced kidney disease.
Ontology highlight
ABSTRACT: Sarcopenia, defined as decrease in muscle function and mass, is common in patients with moderate to advanced chronic kidney disease (CKD) and is associated with poor clinical outcomes. Muscle mitochondrial dysfunction is proposed as one of the mechanisms underlying sarcopenia. Patients with moderate to advanced CKD have decreased muscle mitochondrial content and oxidative capacity along with suppressed activity of various mitochondrial enzymes such as mitochondrial electron transport chain complexes and pyruvate dehydrogenase, leading to impaired energy production. Other mitochondrial abnormalities found in this population include defective beta-oxidation of fatty acids and mitochondrial DNA mutations. These changes are noticeable from the early stages of CKD and correlate with severity of
SUBMITTER: Ertuglu L
PROVIDER: S-EPMC8816417 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA